Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 131.75 M5.26 M8.05 M8.35 M 153.41 M Research & development ———— — Operating income -87.98 M21.68 M23.9 M54.29 M 11.89 M Non-Operating Income, Total -63 K-1.07 M-232 K-165 K -1.53 M Interest expense, net of interest capitalized 527 K563 K615 K0 1.71 M Non-Operating Income, excl. Interest Expenses -527 K-563 K-615 K0 -1.71 M Unusual income/expense -63 K-1.07 M-232 K-165 K -1.53 M Pretax income -128.33 M71.36 M36.63 M79.43 M 59.1 M Equity in earnings ———— — Taxes 35 K-588 K-3.38 M-922 K -4.86 M Non-controlling/minority interest -103.71 M53.97 M29.61 M60.34 M 40.21 M After tax other income/expense ———— — Net income before discontinued operations -34.57 M17.99 M10.4 M20.01 M 13.84 M Discontinued operations ———— — Net income -34.57 M17.99 M10.4 M20.01 M 13.84 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -34.57 M17.99 M10.4 M20.01 M 13.84 M Basic earnings per share (Basic EPS) -2.271.180.671.32 0.9 Diluted earnings per share (Diluted EPS) -2.271.180.651.33 0.89 Average basic shares outstanding 15.24 M15.24 M15.43 M15.38 M 61.29 M Diluted shares outstanding 15.24 M15.24 M15.9 M60.95 M 107.33 M EBITDA -66.72 M45.31 M51.5 M85.55 M 115.65 M EBIT -87.98 M21.68 M23.9 M54.29 M 11.89 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 21.26 M23.63 M27.6 M31.26 M 103.75 M